Generex Biotechnology Corp. added Emmaus Life Sciences Inc. Chairman and CEO Yutaka Niihara to its board of directors as executive chairman.
Generex Biotechnology previously signed a letter of intent to acquire a 51% interest in Emmaus.
Generex adds Emmaus CEO to board
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Investment Banking Essentials Newsletter April Edition - 2022
Generex Biotechnology Corp. added Emmaus Life Sciences Inc. Chairman and CEO Yutaka Niihara to its board of directors as executive chairman.
Generex Biotechnology previously signed a letter of intent to acquire a 51% interest in Emmaus.